SCHEMBL258945

SCHEMBL258945

C=C(C)C(=O)OCC[N+](C)(C)C.CCOP(=O)(O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.47
CHRM5 P08912 6/20 0.47
CHRM1 P11229 6/20 0.47
CHRM3 P20309 6/20 0.47
CHRM2 P08172 5/20 0.44
CHRM4 P08173 5/20 0.44
CHRNB2 P17787 4/20 0.44
CHRNA4 P43681 4/20 0.44
CHRNA7 P36544 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
HTR1A P08908 2/20 0.44
PGR P06401 1/20 0.44
TBXA2R P21731 1/20 0.44
CHRNB4 P30926 1/20 0.44
CHRNA3 P32297 1/20 0.44
CHRNA10 Q9GZZ6 1/20 0.44
CHRNA9 Q9UGM1 1/20 0.44
GALR3 O60755 2/20 0.43
MAPT P10636 1/20 0.43
BLM P54132 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Triethyl Phosphate SCHEMBL7896685 0.89 CHRM5 (0.49) THRBCHRM5CHRM1CHRM3CHRM2
SCHEMBL6462016 0.88 THRB (0.45) THRBCHRM5CHRM1CHRM3CHRM2
Phosphoric Acid SCHEMBL386469 0.87 CHRM5 (0.57) THRBCHRM5CHRM1CHRM3CHRM2
SCHEMBL3457975 0.87 THRB (0.46) THRBCHRM5CHRM1CHRM3CHRM2
Phosphorylethanolamine SCHEMBL27950823 0.85 CHRM5 (0.45) THRBCHRM5CHRM1CHRM3CHRM2
SCHEMBL5145800 0.84 THRB (0.42) THRBTSHR
Phosphocholine SCHEMBL28111186 0.84 TSHR (0.54) THRBCHRM5CHRM1CHRM3TSHR
Phosphoric Acid SCHEMBL9619842 0.84 CHRM5 (0.53) THRBCHRM5CHRM1CHRM3CHRM2
SCHEMBL29199920 0.84 THRB (0.58) THRBTSHRAPEX1
Phosphocholine SCHEMBL15862263 0.84 CHRM5 (0.42) THRBCHRM5CHRM1CHRM3CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 118 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9765213-B2 Drug carriers comprising amphilphilic block copolymers BIOCOMPATIBLES UK LIMITED (GB) 2017-09-19 US claimed
US-20160089445-A1 DERIVATISATION OF BIOLOGICAL MOLECULES BIOCOMPATIBLES UK LIMITED (GB) 2016-03-31 US claimed
US-20140030210-A1 DERIVATISATION OF BIOLOGICAL MOLECULES BIOCOMPATIBLES UK LIMITED (GB) 2014-01-30 US claimed
EP-1480619-B1 DRUG CARRIERS COMPRISING AMPHIPHILIC BLOCK COPOLYMERS BIOCOMPATIBLES UK LTD (GB) 2013-08-07 EP claimed
US-8431113-B2 Polymer conjugates BIOCOMPATIBLES UK LIMITED (GB) 2013-04-30 US claimed
US-20120157550-A1 DRUG CARRIERS COMPRISING AMPHILPHILIC BLOCK COPOLYMERS BIOCOMPATIBLES UK LIMITED (GB) 2012-06-21 US claimed
US-8182802-B2 Cationic block polymers containing 2-methacyloyloxyethyl-2,1-trimethyl ammonium ethyl phosphate liner salt with DNA; drug delivery BIOCOMPATIBLES UK LIMITED (GB) 2012-05-22 US claimed
US-20120016085-A1 POLYMER CONJUGATES BIOCOMPATIBLES UK LIMITED (GB) 2012-01-19 US claimed
US-8048408-B2 addition polymerization of zwitterionic monomers, under molecular weight control, to form polymers having low polydispersity, used for drug delivery BIOCOMPATIBLES UK LIMITED (GB) 2011-11-01 US claimed
EP-1480680-B1 BLOCK COPOLYMERS COMPLEXED WITH NUCLEIC ACIDS BIOCOMPATIBLES UK LTD (GB) 2010-11-03 EP claimed
US-6852816-B2 Zwitterionic polymers BIOCOMPATIBLES UK LIMITED (GB) 2005-02-08 US claimed
EP-1480680-A2 COMPOSITIONS OF POLYMERS Biocompatibles UK Limited (GB) 2004-12-01 EP claimed
EP-1480619-A1 DRUG CARRIERS COMPRISING AMPHIPHILIC BLOCK COPOLYMERS Biocompatibles UK Limited (GB) 2004-12-01 EP claimed
EP-1465933-A1 POLYMER CONJUGATES Biocompatibles UK Limited (GB) 2004-10-13 EP claimed
US-20040063881-A1 Zwitterionic polymers BIOCOMPATIBLES UK LIMITED (GB) 2004-04-01 US claimed
WO-2003074090-A2 COMPOSITIONS OF POLYMERS BIOCOMPATIBLES UK LIMITED (GB) 2003-09-12 WO claimed
WO-2003074026-A1 DRUG CARRIERS COMPRISING AMPHIPHILIC BLOCK COPOLYMERS BIOCOMPATIBLES UK LIMITED (GB) 2003-09-12 WO claimed
WO-2003062290-A1 POLYMER CONJUGATES BIOCOMPATIBLES UK LIMITED (GB) 2003-07-31 WO claimed
EP-1325046-A1 ZWITTERIONIC POLYMERS Biocompatibles UK Limited (GB) 2003-07-09 EP claimed
WO-2002028929-A1 ZWITTERIONIC POLYMERS BIOCOMPATIBLES UK LIMITED (GB) 2002-04-11 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160089445-A1 DERIVATISATION OF BIOLOGICAL MOLECULES IFNG, IFNAR1, IL2 THRB 4097/4885CHRM5 4548/4885CHRM1 4131/4885
US-20120157550-A1 DRUG CARRIERS COMPRISING AMPHILPHILIC BLOCK COPOLYMERS PHOSPHO1, PLA2G2C, ABHD16A THRB 2112/4885CHRM5 1087/4885CHRM1 410/4885
US-20140030210-A1 DERIVATISATION OF BIOLOGICAL MOLECULES IFNG, IFNAR1, IL2 THRB 4097/4885CHRM5 4548/4885CHRM1 4131/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.